Team given $2 million for work on malaria tests | The Triangle

Research is being done on both the preventative and treatment sides of the disease, which would be vaccines and prescription drugs, respectively.

Drexel is also helping investigators in Mumbai, India to identify new antimalarial components by studying and analyzing various active ingredients of formulas already widely used in Indian clinical studies. This research approach is considered “reverse pharmacology” because the formulas have been introduced into a population. Now, on a molecular scale, their effects are being further analyzed to see what new antimalarial compounds can be identified.

The researchers hope not only that the work will create new drugs but also that unveiling different antimalarial compounds will enable the optimization of current antimalarial drugs that are starting to fail.

The NIH grant follows a previous $1 million grant from Medicines for Malaria Venture, a nonprofit based in Geneva. That particular grant funded research at Drexel for three years.

via Team given $2 million for work on malaria tests | The Triangle.

Advertisements


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s